What is ImmuCell (ICCC)?
ImmuCell Corporation is a biotechnology company specializing in the development and commercialization of products aimed at improving animal health, particularly in the dairy industry. The company focuses on providing solutions to prevent and treat diseases in livestock, with an emphasis on enhancing the immunity of newborn calves through its proprietary colostrum-based products. ImmuCell's product portfolio includes treatments designed to reduce the incidence of mastitis and other infections in dairy cows, thereby supporting animal welfare and productivity. The company operates within the animal health sector, serving veterinarians, dairy producers, and livestock farmers. Its research and development efforts are centered on leveraging immunology to address challenges faced in animal agriculture. ImmuCell's activities contribute to the broader field of veterinary medicine by offering alternatives to traditional antibiotics and promoting sustainable farming practices. The company is headquartered in the United States and maintains a presence in markets that prioritize livestock health and dairy production.
ImmuCell Stock Price Today: Live Overview
The price today is shaped by current market levels for ImmuCell, which stands at $6.12. During the session, the price ranged from $5.98 to $6.25, showing a daily change of -5.0713%.
FAQ: ImmuCell (ICCC)
What is the current price of ICCC stock?
The current price is $6.12.
Does ICCC pay dividends?
ImmuCell does not pay dividends.
Does ICCC have a formal corporate presence or regional headquarters in the UAE?
ImmuCell has no official regional office or subsidiary in the UAE and operates through distributors only.
What is ICCC best known for?
ImmuCell is most famous for its development of immunological products for livestock health.
What assets are typically shown together with ICCC?
Commonly shown alongside ICCC: POET Technologies Inc, Unusual Machines, Inc., Western Alliance Bancorp
Latest shares articles



